前收市價 | 9.36 |
開市 | 9.25 |
買盤 | 8.75 |
賣出價 | 9.75 |
拍板 | 6.00 |
到期日 | 2024-05-31 |
今日波幅 | 9.05 - 9.80 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?